Blog

Why We Must Attack Alzheimer's Disease on a Range of Research Fronts

Alzheimer’s is a frustratingly complex disease of mixed origins that expresses itself in different ways. At least 70 percent of its variation remains unexplained. In an age when so much about Alzheimer’s disease is still unknown, a depth and range of funded topics is a necessity. Numerous routes of discovery must be explored. Scientists recognize that it’s unlikely one magic drug will prevent, postpone, or cure Alzheimer’s. Instead, a combination approach, or “cocktail” of different drugs may be necessary to modify or slow the progression of this complicated disease. That makes it all the more important that scientists explore various pathways and stages of the disease to find feasible drug

How Early Should You Be Screened For Breast Cancer?

The American Cancer Society's guidelines say that women should begin getting annual mammograms to screen for breast cancer once they turn 45 — but new research may just change that. A study published in CANCER, a peer-reviewed journal of the ACS, suggests that there may be life-saving value in getting tested even earlier, beginning at age 40. To read the full article, click HERE Written by KIMBERLY TRUONG for Refinery29.com (PHOTOGRAPHED BY ASHLEY ARMITAGE)

Cedars-Sinai Develops New Technology to Detect Alzheimer’s

Finding protein plaques associated with Alzheimer’s disease can often require costly PET scans or invasive spinal taps. But researchers at Cedars-Sinai Medical Center, in conjunction with Sacramento-based NeuroVision Imaging, announced Tuesday they have discovered a way to detect and identify the disease by optically scanning eyeballs. In a peer-reviewed study published in “JCI Insight” last week, the scientists said they were able to employ experimental retinal imaging to detect and identify the beta-amyloid protein deposits that mirror those lodged in the brain. To read the full article, click HERE Written by Dana Bartholomew for the Los Angles Business Journal (Cedars-Sinai Hospital)

Night shifts linked with high breast cancer risk: Study

Women who work in night shifts may be at an increased risk of developing breast cancer, as artificial light blocks a hormone that plays a key role in suppressing growth of its tumours, claims a study. The study, published in journal Environmental Health Perspectives, showed that women who were premenopausal and were current or past smokers, and also who live in areas with high levels of outdoor light at night, were at risk of developing breast cancer - the most common cancer in women worldwide. "In our modern industrialised society, artificial lighting is nearly ubiquitous. Our results suggest that this widespread exposure to outdoor lights during night time hours could represent a novel ris

Research: Diet may help slow effects of Alzheimer's disease

lzheimer’s disease remains the sixth leading killer of Americans, taking the lives of more than 80,000 each year in the United States. But recent research on the effects of the disease provides clues into treatment, said Honor Health family physician Dr. Jeannine Hinds “Studies show the brains of Alzheimer's patients have plaque, deficits of certain brain chemicals and inflammation. Some of these symptoms are directly or indirectly related to chronic disease like diabetes or high blood pressure," Dr. Hinds said. The research suggests that a healthy diet can be an important tool to slowing down the effects of Alzheimer's disease, which begins damaging the brain 15 to 20 years before symptoms

The link between deodorant and breast cancer

ot that long ago, you might have heard about an alarming concern with deodorant. People warned their friends through email and social media that these necessary antiperspirants cause breast cancer. Actually, some people even stopped using deodorant before this threat, such as Cameron Diaz who hasn’t worn it in years! Before ditching your deodorant, though, you should understand the full story behind the concerns about deodorant and breast cancer. First, many people have worries about drugstore deodorants because of parabens. Recently, scientists performed a study which was published in the Journal of Applied Toxicology. The researchers took four samples of breast tissue from 40 women who had

Alzheimer's gene plays role in childhood IQ

The National Institute on Aging acknowledge several causes for Alzheimer's disease, including some genetic factors. One feature of Alzheimer's is a mutation of the gene that encodes amyloid precursor protein (APP), which produces amyloid beta peptides. Amyloid beta forms clusters that build up senile plaques in the brain. Further characteristics and the importance of senile plaques to cognitive functioning are still being researched, however. A new study - led by Dr. Tetyana Zayats and other researchers from the K.G. Jebsen Centre for Neuropsychiatric Disorders in the Department of Biomedicine at the University of Bergen in Norway - has examined further links between APP and the development

New compound boosts treatment for aggressive breast cancer

Triple-negative breast cancer tumors can be particularly aggressive, and they tend to occur in women with a defective BRCA1 gene. It is estimated that approximately 12 percent of breast cancers are triple-negative. New research, which has recently been published in the journal Science Translational Medicine, tests the effect of a novel anticancer agent on treating different types of breast cancer and finds that a new compound - when administered in combination with conventional anticancer drugs - is "highly effective" for treating both triple negative and HER2 positive breast cancers. As the authors of the new study note, treatment for triple-negative breast cancer has seen little improvemen

The Importance Of Revamping The Guidelines For Alzheimer’s Disease

An estimated 5.2 million Americans live with Alzheimer’s disease (AD). Of these Americans, 5 million are over the age of 65 years old. AD is the third leading cause of death in older adults, and is the only top 10 cause of death in the U.S. with no disease modifying treatment or proven treatment for prevention. Even with the statistics mentioned above, it is surprising that the actual diagnosing of the disease remains problematic. Not only is the clinical question regarding “Are there changes in thinking or memory?” not asked in many routine healthcare visits, many cases of dementia go undiagnosed or unclassified. This troubling trend, coupled with the staggering number of projected cases of

Featured Posts
Recent Posts
Archive
Search By Tags
RSS Feed
  • Facebook - White Circle
  • Twitter - White Circle
  • Instagram - White Circle
  • LinkedIn - White Circle

Connect with us on social media

© 2020 Care For A Cure, Inc. is a non-profit organization

with a 501(c)(3) tax exempt status. All rights reserved.